AbbVie Inc (ABBV)-医療機器分野:企業M&A・提携分析

GlobalDataが発行した調査報告書(DATA8013843)
◆英語タイトル:AbbVie Inc (ABBV) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8013843
◆発行会社(リサーチ会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:66
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

Summary
AbbVie Inc (AbbVie) is a research-based biopharmaceutical company that carries out the research, development, manufacture and commercialization of advanced therapies to treat complex and serious diseases. The company focuses on providing drugs in immunology, cancer, neuroscience and virology and general medicine therapy areas. Its products are used to treat rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, osteoarthritis, plaque psoriasis, psoriatic arthritis, hidradenitis suppurativa, Crohn’s disease, ulcerative colitis, systemic lupus erythematosus, chronic lymphocytic leukemia, small cell lung cancer, relapsed/refractory marginal zone lymphoma, Alzheimer’s disease, multiple sclerosis, Parkinson’s disease, hepatitis C (HCV), human immunodeficiency virus (HIV) and other serious health conditions. AbbVie sells its products worldwide directly to wholesalers, distributors, health care facilities, government agencies, specialty pharmacies and independent retailers through its owned distribution centers and public warehouses. The company operates through subsidiaries in North America, South America, Asia, Europe, Middle East and South Africa. AbbVie is headquartered in North Chicago, Illinois, the US.

AbbVie Inc (ABBV) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
AbbVie Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
AbbVie Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
AbbVie Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
AbbVie Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 9
AbbVie Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
AbbVie Inc, Medical Equipment, Deal Details 11
Venture Financing 11
Stem CentRx Raises more than USD100 Million in Financing Round 11
Partnerships 12
AbbVie Enters into Licensing Agreement with Cerveau Technologies 12
Enterome Enters into Co-Development Agreement with AbbVie 13
Abbott Molecular Enters Into Agreement With Janssen Biotech And Pharmacyclics For Leukemia Test 14
Debt Offering 15
AbbVie Raises USD795.6 Million in Public Offering of 2.13% Notes Due 2028 15
AbbVie Raises USD1.53 Billion in Public Offering of 1.38% Notes Due 2024 16
AbbVie Raises USD1.48 Billion in Public Offering of 0.38% Notes Due 2019 17
AbbVie Raises USD1 Billion in Public Offering of 3.2% Notes Due 2022 18
AbbVie Raises USD2.7 Billion in Public Offering of 4.7% Notes Due 2045 20
AbbVie Raises USD3.75 Billion in Public Offering of 2.5% Notes Due 2020 22
AbbVie Raises USD3 Billion in Public Offering of 1.8% Notes Due 2018 24
AbbVie Raises USD3.75 Billion in Public Offering of 3.6% Notes Due 2025 26
AbbVie Raises USD2.5 Billion in Public Offering of 4.5% Notes Due 2035 28
AbbVie Raises USD4 Billion in Public Offering of 1.75% Notes Due 2017 30
AbbVie Raises USD3.1 Billion in Public Offering of 2.9% Notes Due 2022 31
AbbVie Raises USD2.6 Billion in Public Offering of 4.4% Notes Due 2042 32
AbbVie Raises USD1 Billion in Public Offering of 2% Notes Due 2018 33
AbbVie Inc – Key Competitors 34
AbbVie Inc – Key Employees 35
AbbVie Inc – Locations And Subsidiaries 36
Head Office 36
Other Locations & Subsidiaries 36
Recent Developments 44
Financial Announcements 44
Oct 27, 2017: AbbVie Reports Third-Quarter 2017 Financial Results 44
Jul 28, 2017: AbbVie Reports Second-Quarter 2017 Financial Results 46
Apr 27, 2017: AbbVie Reports First-Quarter 2017 Financial Results 48
Jan 27, 2017: AbbVie Reports Full-Year and Fourth-Quarter 2016 Financial Results 50
Oct 28, 2016: AbbVie Reports Third-Quarter 2016 Financial Results 52
Jul 29, 2016: AbbVie Reports Second-Quarter 2016 Financial Results 54
Apr 28, 2016: AbbVie Reports First-Quarter 2016 Financial Results 56
Jan 29, 2016: Abbvie Reports Full-Year 2015 And Fourth-Quarter Financial Results 58
Corporate Communications 60
Sep 07, 2017: AbbVie Leads Biotechnology Industry on Dow Jones Sustainability Index for Second Consecutive Year 60
Jan 15, 2016: AbbVie appoints Esteban Plata, Vice President, Western Europe & Canada, replaces Pascale Richetta who retires from AbbVie 61
Legal and Regulatory 62
Jul 31, 2017: AbbVie Announces Delisting from Euronext Paris 62
Product News 63
May 17, 2017: AbbVie to Present Latest Clinical Study Results in Hematology and Solid Tumor Research at the 53rd American Society of Clinical Oncology Annual Meeting 63
Jun 03, 2016: AbbVie to Highlight its Innovative Pipeline to the Investment Community 65
Appendix 66
Methodology 66
About GlobalData 66
Contact Us 66
Disclaimer 66

List of Tables
AbbVie Inc, Medical Equipment, Key Facts, 2016 2
AbbVie Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
AbbVie Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
AbbVie Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
AbbVie Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
AbbVie Inc, Deals By Market, 2011 to YTD 2017 9
AbbVie Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Stem CentRx Raises more than USD100 Million in Financing Round 11
AbbVie Enters into Licensing Agreement with Cerveau Technologies 12
Enterome Enters into Co-Development Agreement with AbbVie 13
Abbott Molecular Enters Into Agreement With Janssen Biotech And Pharmacyclics For Leukemia Test 14
AbbVie Raises USD795.6 Million in Public Offering of 2.13% Notes Due 2028 15
AbbVie Raises USD1.53 Billion in Public Offering of 1.38% Notes Due 2024 16
AbbVie Raises USD1.48 Billion in Public Offering of 0.38% Notes Due 2019 17
AbbVie Raises USD1 Billion in Public Offering of 3.2% Notes Due 2022 18
AbbVie Raises USD2.7 Billion in Public Offering of 4.7% Notes Due 2045 20
AbbVie Raises USD3.75 Billion in Public Offering of 2.5% Notes Due 2020 22
AbbVie Raises USD3 Billion in Public Offering of 1.8% Notes Due 2018 24
AbbVie Raises USD3.75 Billion in Public Offering of 3.6% Notes Due 2025 26
AbbVie Raises USD2.5 Billion in Public Offering of 4.5% Notes Due 2035 28
AbbVie Raises USD4 Billion in Public Offering of 1.75% Notes Due 2017 30
AbbVie Raises USD3.1 Billion in Public Offering of 2.9% Notes Due 2022 31
AbbVie Raises USD2.6 Billion in Public Offering of 4.4% Notes Due 2042 32
AbbVie Raises USD1 Billion in Public Offering of 2% Notes Due 2018 33
AbbVie Inc, Key Competitors 34
AbbVie Inc, Key Employees 35
AbbVie Inc, Subsidiaries 36

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ AbbVie Inc (ABBV)-医療機器分野:企業M&A・提携分析(AbbVie Inc (ABBV) - Medical Equipment - Deals and Alliances Profile)]についてメールでお問い合わせはこちらでお願いします。

◆H&Iグローバルリサーチのお客様(例)◆